Company Research

Open search
Tenzing MEMO publishes independent research you won't find anywhere else. Sign up for a free trial to access everything — including 18 articles published in the last two weeks.
Sign Up
Vertex Pharmaceuticals Incorporated (VRTX)
Locked

The Kidney Franchise the Market Hasn't Priced

The familiar standoff—elite CF monopoly versus a full multiple and a maturing core—resolves in the buyers' favor once you weight the catalysts by how knowable they are. CF is converting toward ALYFTREK on a long exclusivity runway and funding everything else; that is the demon...

Read Article ›
Hawaiian Electric Industries, Inc. (HE)
Locked

The Legal Cliff Is Past, But the Earnings Climb Is Just Starting

Hawaiian Electric has graduated from tail-risk to execution risk, and that is a genuine improvement in the quality of the investment. The legal cliff is behind it: the global settlement is final, the releases are effective, and the first $479 million installment is paid.

Read Article ›
Alphabet Inc. (GOOG)
Locked

Alphabet's 2027 Revenue Tell Is Hiding Behind the CapEx Noise

Alphabet is three businesses wearing one ticker: an advertising machine (Search, YouTube, the Google Network) that still throws off the cash, a hyperscale cloud and AI infrastructure arm that has only recently become a real profit center, and a portfolio of long dated bets led...

Read Article ›
Lumen Technologies, Inc. (LUMN)
Locked

The Solvency Trade Is Over, The Execution Trade Has Just Begun

Lumen is no longer the same company that frightened credit analysts two years ago. Strip away the legacy CenturyLink copper businesses and what remains is an enterprise and wholesale network operator built around three things: a 340,000 route mile fiber backbone, a fast growin...

Read Article ›
Tradeweb Markets Inc. (TW)

A Business Visibly Accelerating While the Share Price Retreats

The company is printing record revenue, expanding swaps share across every major currency, growing international past 40% of the mix, and converting more than $1 billion to free cash flow — yet the stock sits near a 52-week low because investors have fixated on a fee-per-milli...

Read Article ›